Opioid and cocaine use among primary care patients on buprenorphine—Self-report and urine drug tests

Alford, 2011, Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience, Arch. Int. Med., 171, 425, 10.1001/archinternmed.2010.541 Chermack, 2000, Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions, Drug Alcohol Depend, 59, 43, 10.1016/S0376-8716(99)00106-4 Denis, 2012, Validity of the Self-Reported Drug Use Section of the Addiction Severity Index and associated factors used under naturalistic conditions, Subst. Use Misuse, 47, 356, 10.3109/10826084.2011.640732 Fiellin, 2008, Long-term treatment with buprenorphine/naloxone in primary care: results at 2–5 years, Am. J. Addict., 17, 116, 10.1080/10550490701860971 Hilario, 2015, Denial of urinalysis-confirmed opioid use in prescription opioid dependence, J. Subst. Abuse Treat., 48, 85, 10.1016/j.jsat.2014.07.003 Kirsh, 2015, A survey of ASAM members’ knowledge, attitudes, and practices in urine drug testing, J. Addict. Med., 9, 399, 10.1097/ADM.0000000000000146 Manhapra, 2018, Three-year retention in buprenorphine treatment for opioid use disorder among privately insured adults, Psychiatr. Serv., 69, 768, 10.1176/appi.ps.201700363 Massachusetts Department of Public Health, 2018 McDonell, 2016, Utility of point-of-care urine drug tests in the treatment of primary care patients with drug use disorders, J. Addict. Med., 10, 196, 10.1097/ADM.0000000000000220 Merrill, 2002, Mutual mistrust in the medical care of drug users, J. Gen. Intern. Med., 17, 327 Samet, 2018, Suggested paths to fixing the opioid crisis: directions and misdirections, JAMA Netw. Open, 1, 10.1001/jamanetworkopen.2018.0218 Substance Abuse and Mental Health Services Administration (SAMHSA), 2018 Stein, 2005, Brief report: buprenorphine retention in primary care, J. Gen. Intern. Med., 20, 1038, 10.1111/j.1525-1497.2005.0228.x Sullivan, 2011, The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone, J. Acquir. Immune Defic. Syndr., 56, S54, 10.1097/QAI.0b013e3182097576 Velez, 2017, “It’s been an experience, a life learning experience”: a qualitative study of hospitalized patients with substance use disorders, J. Gen. Intern. Med., 32, 296, 10.1007/s11606-016-3919-4 Wilcox, 2013, Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants, Addict. Behav., 38, 2568, 10.1016/j.addbeh.2013.05.015